Latest Nutrition News

5Jan
2023

Patients, Doctors Await FDA Decision on Experimental Alzheimer’s Drug

Patients, Doctors Await FDA Decision on Experimental Alzheimer’s DrugTHURSDAY, Jan. 5, 2023 (HealthDay News) -- Lecanemab: It's an experimental medication that's been shown in trials to slow cognitive decline in people with Alzheimer’s disease. It's also up for accelerated approval by the U.S. Food and Drug Administration, with a decision expected by Jan. 6.However, the drug has also been linked to two deaths from brain bleeds among people who’ve used it in trials, so safety concerns could threaten any approval. If approved, the drug — made by Japanese pharmaceutical company Eisai — would follow the controversial drug Aduhelm to become only the second medication ever approved to slow Alzheimer’s disease. Not every patient would stand to benefit from lecanemab, stressed the Cleveland Clinic’s Dr. Babak Tousi. He led the portion of the...

Resolved to Lose Weight in 2023? Experts Compare Popular...

3 January 2023
Resolved to Lose Weight in 2023? Experts Compare Popular DietsTUESDAY, Jan. 3, 2023 (HealthDay News) -- Losing weight is one of the most popular New Year's resolutions -- possibly to give yourself an excuse for some New Year's Eve overindulgence."I'm going to cram it all in tonight, so tomorrow I start afresh," jokes registered dietitian Connie Diekman, a nationally known food and nutrition consultant.But those waking up bleary-eyed on New Year's Day will find themselves facing a bewildering array of fad diets and quick weight-loss schemes.Which would be best for you?In large part, it's going to be the diet that you can incorporate into your everyday life to improve your health rather than lose weight, Diekman said."Making changes to our eating habits is a process. It takes time. Give yourself a break," Diekman said. "Set one goal at a time. Work...

Staying Hydrated Could Mean Less Disease, Slower Aging

3 January 2023
Staying Hydrated Could Mean Less Disease, Slower AgingTUESDAY, Jan. 3, 2023 (HealthDay News) -- Could hydration hold the key to longevity?Maybe, suggests new research that discovered older adults who are properly hydrated may be healthier and live longer than those who aren't, having less incidence of conditions like heart and lung disease."Staying well-hydrated may slow down aging, prevent or delay development of chronic diseases, and therefore prolong disease-free life," said lead investigator Natalia Dmitrieva, a researcher from the Laboratory of Cardiovascular Regenerative Medicine at the U.S. National Heart, Lung and Blood Institute."The best way for people to keep well-hydrated is to be aware of the amount of fluids they drink without engaging in intensive sports activities or [spending] a long time in a hot environment," Dmitrieva...

Drug Approved to Help Young Patients Battle a Rare Cancer

2 January 2023
Drug Approved to Help Young Patients Battle a Rare CancerMONDAY, Jan. 2, 2023 (HealthDay News) -- Children and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big impact. The U.S. Food and Drug Administration has approved the immunotherapy drug atezolizumab (Tecentriq) for use in patients with advanced alveolar soft part sarcoma (ASPS) that has spread to other parts of the body or cannot be removed by surgery.“This approval will make a huge impact in terms of a rare disease that has been particularly challenging to treat,” said Dr. Alice Chen, of the Developmental Therapeutics Clinic in the U.S. National Cancer Institute’s (NCI) Division of Cancer Treatment and Diagnosis (DCTD).This cancer begins in the soft tissue that connects and surrounds the organs and other tissues. It spreads...

Congressional Report Slams FDA, Drugmaker Over Approval of Alzheimer's Drug Aduhelm

29 December 2022
Congressional Report Slams FDA, Drugmaker Over Approval of Alzheimer`s Drug AduhelmTHURSDAY, Dec. 29, 2022 (HealthDay News) -- The U.S. Food and Drug Administration's approval process for the controversial Alzheimer's drug Aduhelm was "rife with irregularities," despite lingering doubts about the power of the pricey medication to slow the disease down, a Congressional report released Thursday claims.Actions the agency took with Biogen, maker of Aduhelm, "raise serious concerns about FDA’s lapses in protocol," the report concluded. But the 18-month investigation launched by two congressional committees also took Biogen to task for setting too high a price on the medication.Company documents showed Biogen officials settled on an annual cost of $56,000 for Aduhelm because it wanted to “establish Aduhelm as one of the top pharmaceutical launches of all time,” even...
RSS
123468910Last
HealthDay

Copyright © 2018 HealthDay. All rights reserved.